Data from EXPLORER-HCM Study Selected for Virtual Late-Breaker Presentation at the European Society of Cardiology Congress 2020
Topic: Hypertrophic Cardiomyopathy
Session: Hot Line
Presentation: EXPLORER-HCM: Efficacy and Safety of Mavacamten in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
Investor and Analyst Conference Call and Live Webcast
To access the call, please dial (844) 494-0193 (
MyoKardia’s mission is to change the world for people with serious cardiovascular disease through bold and innovative science.
Executive Director, Corporate Communications and Investor Relations
Stern Investor Relations, Inc.
Source: MyoKardia, Inc.